Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance. - Barron's
Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance. Barron's
Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance. Barron's
每周整理公司动态、产品信号、监管更新、融资和重要新闻。